» Articles » PMID: 8989831

Regulation of Skeletal Muscle Protein Turnover During Sepsis: Mechanisms and Mediators

Overview
Journal Shock
Date 1997 Jan 1
PMID 8989831
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Skeletal muscle protein wasting is a prominent feature of the metabolic response to sepsis. Persistent protein wasting leads to muscle dysfunction and prolongs recovery from the septic insult. Unfortunately, conventional nutritional support alone does not prevent the sepsis-induced weight loss and catabolism of muscle. Hence, mechanisms other than substrate deficiency appear to be involved in the derangements in protein metabolism during sepsis. The catabolism of muscle during sepsis results from a stimulation of proteolysis and an inhibition of protein synthesis. This review summarizes the mechanisms responsible for alterations in protein synthesis and degradation in muscle during sepsis at the biochemical level. The ability of hormones (insulin, insulin-like growth factor I, glucocorticoids) or cytokines (tumor necrosis factor, interleukin-1) to act as mediators of protein catabolism is also examined. Finally, we discuss the potential role of anticytokine therapies in preventing derangements in protein metabolism during sepsis. A picture is emerging which suggests that cytokines may influence skeletal muscle protein metabolism during sepsis both indirectly through inhibition of the regulatory actions of anabolic hormones on protein turnover, and directly through modulation of the protein synthesis and degradation enzymatic machinery.

Citing Articles

Identifying potential biomarkers and therapeutic targets for dogs with sepsis using metabolomics and lipidomics analyses.

Montague B, Summers A, Bhawal R, Anderson E, Kraus-Malett S, Zhang S PLoS One. 2022; 17(7):e0271137.

PMID: 35802586 PMC: 9269464. DOI: 10.1371/journal.pone.0271137.


Nuclear magnetic resonance-based serum metabolomic analysis reveals different disease evolution profiles between septic shock survivors and non-survivors.

Liu Z, Triba M, Amathieu R, Lin X, Bouchemal N, Hantz E Crit Care. 2019; 23(1):169.

PMID: 31088568 PMC: 6518644. DOI: 10.1186/s13054-019-2456-z.


Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in locomotor and respiratory muscles during experimental sepsis in mice.

Morel J, Palao J, Castells J, Desgeorges M, Busso T, Molliex S Sci Rep. 2017; 7(1):10866.

PMID: 28883493 PMC: 5589872. DOI: 10.1038/s41598-017-11440-5.


Metabolic Inflammatory Complex in Sepsis: Septic Cachexia as a Novel Potential Therapeutic Target.

Kaneki M Shock. 2017; 48(6):600-609.

PMID: 28520694 PMC: 8675641. DOI: 10.1097/SHK.0000000000000906.


Urine metabolomics in neonates with late-onset sepsis in a case-control study.

Sarafidis K, Chatziioannou A, Thomaidou A, Gika H, Mikros E, Benaki D Sci Rep. 2017; 7:45506.

PMID: 28374757 PMC: 5379623. DOI: 10.1038/srep45506.